From: Micropeptides: potential treatment strategies for cancer
Subcellular localization | NcRNAs | Micropeptide | Size | Cancer types | Function | Reference |
---|---|---|---|---|---|---|
Membrane | LncRNARP11-469H8.6 | MIAC | 51 aa | HNSCC | Interacts with AQP2 and reduces the expression of ITGB4 and SEPT2, inhibiting tumour growth and metastasis | 61 |
LINC00998 | SMIM30 | 59 aa | HCC | Activates the MAPK pathway to promote proliferation and metastasis of tumour | 54 | |
lncRNA DLEU1 | ORF1,ORF8 | - | Glioma | Forms a pentameric structure with ion channel activity, increases brain oedema and the risk of cancer cell development | 63 | |
Cytoplasm | LINC00665 | CIP2A-BP | 52 aa | TNBC | Directly binds to the oncogene CIP2A and inhibits the PI3K/AKT signalling pathway, thus inhibiting the migration and invasion of TNBC. | 67 |
LINC00278 | YY1BM | 21 aa | ESCC | Inhibits the interaction of YY1 and androgen receptor and reduces the expression of Eef2k | 70 | |
LINC00908 | ASRPS | 60 aa | TNBC | Inhibits STAT3 phosphorylation, reduces VEGF expression, and then inhibits tumour angiogenesis | 58 | |
LINC01420 | NOBODY | 7Â kDa | Lung cancer | Affect underlying cancer cells processes by regulating the decay of mRNA | 66 | |
lncRNA NCBP2-AS2 | KRASIM | 99 aa | HCC | Inhibits the growth and proliferation of HCC cells | 68 | |
Circ-AKT3 | AKT3-174aa | 174 aa | GBM | Inhibits AKT-thr308 phosphory-lation and PI3K/AKT signalling pathway activation | 69 | |
Endoplasmic reticulum | lncRNA ASH1L-AS1 | APPLE | 90 aa | AML | Promotes the development of different subtypes of AML | 72 |
LINC00675 | FORCP | 79 aa | CRC | Inhibits basal cell proliferation and tumorigenesis | 73 | |
Endosomes | - | CASIMO1 | 83 aa | BC | Interacts with squalene epoxidase (SQLE) to influence cell proliferation and cycle progression | 79 |
lncRNA LINC00961 | SPAR | 90 aa | Lymphoma | Reduces the effects of amino acid-sensing pathway activated by mTORC1 and exerts antitumour effects | 80 | |
Mitochondria | LINC00467 | ASAP | 94 aa | CRC | Promotes cancer cell proliferation by regulating the production of ATP | 85 |
LINC00116 | MPM | 56 aa | HCC | Promotes hepatocellular carcinoma metastasis by increasing mitochondrial complex I activity and the NAD+/NADH ratio | 86 | |
- | PIGBOS | 54 aa | - | Regulates the unfolded protein response and cell death | 87 | |
- | STMP1 | 47 aa | HCC | Promotes G1/S conversion and cell proliferation by enhancing the activity of mitochondrial complex IV | 89,90 | |
5’UTR of PTEN | MP31 | 31 aa | GBM | Limits lactate-pyruvate conversion in mitochondria | 32 | |
miR-34a | miPEP133 | 133 aa | NPC | Binds HSPA9 to reduce mitochondrial membrane potential and mitochondrial mass, and inhibits tumour growth | 93 | |
Nucleus | lncRNA CTD-2256P15.2 | PACMP | 44 aa | BC | Maintains nucleolus homeostasis and promotes the DNA damage response | 95 |
LOC90024 | SRSP | 130 aa | CRC | Incerases SRSP levels, which are positively correlated with a malignant phenotype and poor prognosis | 96 | |
LINC00266-1 | RBRP | 71 aa | CRC | Promotes proliferation, colony formation, migration and invasion of cancer cells | 57 | |
lncRNA HOXB-AS3 | HOXB-AS3 | 53 aa | CRC | Inhibits the proliferation, migration and invasion of cancer cells | 101 | |
Linc013026 | Linc013026-68AA | 68 aa | HCC | Promotes the proliferation of cancer cells | 103 | |
lncRNA | UBAP1-AST6 | 117 aa | Lung cancer | When overexpressed promotes the proliferation of lung cancer cells | 60 | |
Linc00176 C20orf204 | C20orf204-189AA | 189 aa | HCC | Stabilizes nucleolin and promotes nucleosomal DNA transcription | 105 | |
circ-0000437 | CORO1C-47aa | 47 aa | Endometrial cancer | Inhibits endothelial cell proliferation and tumour angiogenesis | 20 |